Neuromed Pharmaceuticals, Ltd., a biopharmaceutical company, develops, produces, markets, and sells pain therapies.
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States.Neuromed Pharmaceuticals was acquired by Zalicus in December 2009.Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 8, 2006 | Series D | $25M | 1 | — | — | Detail |
Nov 4, 2003 | Series C | $32M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Cogene Ventures | — | Series D |